Johnson & Johnson seeks full FDA approval for Intelence.
D019380:Anti-HIV Agents; D006801:Humans; D017387:Investigational New Drug Application; D009570:Nitriles; D011724:Pyridazines; D011743:Pyrimidines; D014481:United States
D019380:Anti-HIV Agents; D009570:Nitriles; D011724:Pyridazines; D011743:Pyrimidines; C451734:etravirine